Clinical Trial Technology Editorial

  1. Clinical News Roundup: Bioclinica To Be Acquired By Cinven
    8/26/2016

    Clinical news roundup for the week of August 22, 2016 with information on the Bioclinica acquisition by Cinven, SCRS Eagle Award finalists, supporting kids with brain tumors, reducing risk in adaptive trials, Zika testing in humans, and more.

  2. Clinical News Roundup: Can Clinical Trials On Pets Help People?
    8/12/2016

    Clinical news roundup for the week of August 8, 2016 with articles on using pets in clinical trials, the Quintiles/DaVita alliance, the benefits and pitfalls of data sharing, and the Orphan Drug Act.

  3. How RBM Is Changing The Role Of Monitors
    8/11/2016

    Is risk-based monitoring (RBM) changing the role of monitors in clinical trials? In the latest issue of the Pharmaceutical Outsourcing Monitor, Michael Martorelli of Fairmount Partners takes a look at this issue, and features some interesting feedback from readers along with informative insights from Jim Kremidas of ACRP and Clara Heering of ICON. How is RBM changing the role of monitors and what do you need to know?

  4. J&J Takes The Lead In Clinical Data Transparency
    8/10/2016

    It’s a problem that clinical researchers have dealt with for years. A researcher has an idea for a study. They identify an existing data set, produced by other researchers, which would be ideal for that particular study. Although that data is not currently being used, the researcher is not able to access and use the clinical trial data because it is not being shared. This is a situation that Johnson & Johnson (J&J) is hoping to change.

  5. Survey: Do Spreadsheets Still Hamper Clinical Trial Speed & Quality?
    8/8/2016

    Clinical trial operations is fraught with many hurdles, including quality, cost, and timeliness. To successfully bring new medicines to market, operations managers have to successfully overcome these challenges. Application software provider Comprehend recently produced a “Clinical Operations Benchmark Report,” in which it surveyed executives at leading life science companies. The goal was to determine how companies can speed up trials and more quickly get to quality results across a portfolio of products.

  6. IN CASE YOU MISSED IT: Clinical Leader Top 3 Articles For July 2016
    8/1/2016

    Below are my top three articles downloaded on Clinical Leader for the month of July 2016. In case you missed them, please take this opportunity to see what everyone else was learning about GSK’s bold moves into mHealth, the efforts of Duke and PCORI to transform clinical trials, and the coming mHealth tsunami.  

  7. Clinical News Roundup: Is ClinicalTrials.gov Failing Patients?
    7/29/2016

    Clinical news roundup for the week of July 25, 2016 with information on ClinicalTrials.gov, patient empowerment, wearable technologies in clinical trials, clinical trial information, and India lagging in hepatitis research.

  8. 3 Patient-Centric Steps to Increase Retention
    7/26/2016

    Patient centricity is a growing trend in our industry. From the creation of Chief Patient Officer positions to culture-change initiatives, one of the strategies to improve the quality of clinical trials is to treat patients as “consumers” rather than “subjects” in a study.

  9. Are Your Clinical Trials Prepared For The Coming mHealth Tsunami?
    7/18/2016

    Excitement around mHealth technologies has been building for years. While initial apprehension kept many companies from jumping into the space, sensors are finally starting to make it onto patients. In this Q&A, Glen de Vries, president of Medidata Solutions, discusses progress the industry has made, concerns that remain, and what the future holds for mobile and wearable technologies.  

  10. Study Rescue: How To Get Your Clinical Trial Back On Track
    7/13/2016

    Beth Harper has devoted more than 28 years of her life to the world of clinical research, including time at a sponsor, CRO, service provider, and start-up company while also serving as an adjunct associate professor at George Washington University. She is currently president of Clinical Performance Partners, where she works with companies to optimize study feasibility and site selection and helps to improve site relationship management practices. Although her passion is to work on proactive protocol and site performance optimization strategies, she will tell you that most of her time is spent rescuing studies. In this Q&A, Harper shares her insights on the factors that will lead to a study rescue and what companies can do to prevent that situation from arising.